Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Actuate Therapeutics Inc.
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University Hospital, Ghent
Celgene
Western Regional Medical Center
Incyte Corporation
University of California, San Francisco